New pathway of the energy metabolism in peripheral tissues regulated by cytokine GDF15 –

Forget Password?
Learn more
share this!
September 15, 2021
A study published in the journal Cell Reports describes a new pathway related to the activity of receptors that are associated with several metabolic or cardiovascular diseases such as diabetes, obesity and hypertension. According to the conclusions, many antidiabetic effects of the activators of the PPARβ/δ receptors —potential therapeutic targets for the treatment of type 2 diabetes— are regulated by cytokine GDF15, a protein expressed under conditions of physiological stress.

googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1449240174198-2’); });

The study contributes to find new therapeutic pathways for the treatment of metabolic dysfunctions and it is led by Professor Manuel Vázquez-Carrera, from the Faculty of Pharmacy and Food Sciences, the Institute of Biomedicine of the University of Barcelona (IBUB), the Research Institute Sant Joan de Déu (IRSJD) and the Diabetes and Associated Metabolic Diseases Networking Biomedical Research Centre (CIBERDEM).
Cytokine GDF15, a factor that regulates the energy metabolism
PPARs (perosyxomel proliferator activated ) are transcription factors of the superfamily of hormone nuclear receptors. The dysfunctions of these receptors are related to several metabolic or cardiovascular pathologies which have a high incidence in the population.
The paper published in Cell Reports confirms that many antidiabetic effects of the PPARβ/δ activators work through the cytokine GDF15, and which is more important, independently from the activation of the GFRAL neuronal receptor, which was the most known pathway to date. The new regulation pathway works through the activation of the AMPK protein, a sensor of the energy metabolism in the cell.
“The GDF15 or growth differentiation factor 15 is a stress-response cytokine—with increased levels in many diseases such as heart failure, cancer, , etc.)—which has been suggested as potential biomarker of many diseases,” notes Manuel Vázquez-Carrera, professor at the Department of Pharmacology, Toxicology and Therapeutical Chemistry.
This cytokine is expressed in multitude of cells, tissues and organs (liver, skeletal muscle, adipose tissue, kidney, heart, placenta, macrophages, etc.). Its expression increases under situations of intracellular organelle stress (mitochondrial stress or endoplasmic reticulum stress) and environmental factors (excess of nutrients).
“Recent studies had shown that the cytokine GDF15 shows beneficial effects on the metabolism through the activation of its GFRAL receptor in the brain. Once the GFRAL receptor is activated, the intake decreases, and as a result, there is a weight loss that can reduce obesity and would improve associated diseases such as type 2 diabetes,” notes Vázquez-Carrera.
AMPK activation route through cytokine GDF15
The study shows how the activation of AMPK through GDF15 increases the levels of GDF15, which increases the activation of the same AMPK in the skeletal muscle and indecently the GFRAL receptor in the brain.
“We believe this pathway is a positive feedback system that would maintain the AMPK activated in a sustained manner,” notes Vázquez-Carrera. “Therefore, cytokine GDF15 shows peripheral effects, not only central ones.”
Specifically, AMPK is activated in situations marked by a low level of cell energy and glucose. Once activated, AMPK starts a series of catabolic processes (degradation) that generate ATP—the molecule that carries chemical energy—and at the same time it inhibits the anabolic processes (synthesis) that take ATP.
“This activation mechanism is important because AMPK is a key regulator of many processes related to the cellular energy metabolism (increase of glucose uptake and the oxidation of fatty acids, increase of mitochondrial oxidative capacity, improvement of insulin tolerance, etc.)”, says the researcher.
New therapeutic targets to fight metabolic diseases
The activation pathway of AMPK through GDF15 is a key mechanism against type 2 diabetes because “there are currently several medicines that activate AMPK which are considered safe drugs. Regarding the GFRAL activation through GDF15, the potential effects this could cause are still unknown. An overstimulation of this neuronal receptor could involve the appearance of adverse effects we should consider,” notes the researcher.
“In this context, the high levels of GDF15 produced in cancer and the following activation of GFRAL have been presented as one of the mechanisms responsible for the appearance of cachexia—i.e, the extreme malnutrition and muscle atrophy—associated with this disease. This led researchers to study the use of antibodies against GDF15 to fight against the cachexic state.”

Explore further

The body produces new satiety factor during prolonged exercise

More information: David Aguilar-Recarte et al, GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK, Cell Reports (2021). DOI: 10.1016/j.celrep.2021.109501

Journal information: Cell Reports

Citation: New pathway of the energy metabolism in peripheral tissues regulated by cytokine GDF15 (2021, September 15) retrieved 17 September 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further
Feedback to editors
Sep 16, 2021
Sep 15, 2021
Sep 15, 2021
Sep 15, 2021
Sep 14, 2021
1 hour ago
2 hours ago
2 hours ago
2 hours ago
3 hours ago
3 hours ago
3 hours ago
10 hours ago
16 hours ago
21 hours ago
22 hours ago
Sep 15, 2021
Sep 15, 2021
More from Biology and Medical
Feb 16, 2021
Oct 02, 2017
Dec 09, 2019
Jan 15, 2019
Jan 06, 2021
Oct 10, 2018
6 hours ago
2 hours ago
4 hours ago
22 hours ago
22 hours ago
Sep 16, 2021
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
Medical research advances and health news
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.